Insider buying last 90 days
No open-market insider purchases were filed for BRO in the last 90 days.
From Form 4 filings, dated to when each was filed.
Nov 13 close
Brown & Brown's week centers on its Q3 report and the launch of its COMPASS data and AI platform, alongside continued integration of Accession, for which 2026 EBITDAC synergies were raised to $50 million. The company reported Q3 revenue of $1.7 billion, up 7.4%, with organic growth of 1.2%, while adjusted EPS grew to $1.07, missing the $1.09 estimate and prompting a -7.4% reaction. Commentary has also touched on a healthcare benefits survey and the broader investment narrative around the brokerage's resilience. Analyst actions were mixed, with BMO Capital raising its target to $74 while maintaining a Market Perform rating, and UBS Group trimming its target to $72 while keeping a neutral stance.
The stock closed at $71.00, down 1.6% on the day, but sits above both its 50-day average of $66.93 and 200-day average of $66.42, with the 50-day above the 200-day. Momentum has been strong over one month (12.9%) and six months (28.3%), though the one-year return stands at -7.1%. The GekkoIndex reads 54.4, placing it in the Neutral zone, and the price sits 1.5% above Gekko Fair Value of $69.93.
Over the next 20 trading days, the next earnings date falls on 25 January 2027, 71 days away, placing it outside a typical holding window. No insider, Congress, or unusual options activity appears in their respective windows. Seasonally, this calendar point has historically produced an average 20-day return of 2.6% over five years, with gains in three of those years, a pattern worth noting alongside the current gap to fair value.
Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.
Brown & Brown scores 3 supportive, 2 mixed and 0 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive2 mixed0 headwinds
Above 50 and 200-day
Close $71.93 is above the 50-day ($66.87) and 200-day ($66.36) averages, and the 50-day is above the 200-day.
See the chart55.6, Neutral
Reading 55.6 is in the Neutral zone.
See the GekkoIndex2.7% above
Price is within 5% of Gekko Fair Value (2.7% above).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 71 days
Next report Jan 25, 2027, 71 days away — outside a typical 20-trading-day hold.
See earnings+1.6% on average
From this point in the calendar, the next 20 trading days averaged +1.6% over 5 years, rising in 4 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Brown & Brown closed at $71.93 on Nov 13, 2026, −10.3% over the past year, inside a 52-week range of $53.81 to $82.58.
Use the left and right arrow keys to read daily values.
Put BRO on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Brown & Brown works as an insurance broker, arranging coverage and related services across the United States, Bermuda, Canada, Ireland, the United Kingdom and the Cayman Islands. It serves commercial businesses, public and quasi-public bodies, professionals and individual clients, offering property and casualty cover, employee benefits, personal insurance and specialized policies, along with loss control reviews, consulting and claims handling.
The business runs through four segments. Retail handles the broad insurance and advisory work described above. National Programs concentrates on professional liability and bundled coverage for fields such as dentistry, law, optometry, finance, medicine and real estate title work, plus event, medical facility and cyber risk products, and it also performs outsourced tasks like underwriting, marketing, actuarial work and compliance for insurance carriers, managing flood insurance and public entity programs mainly through independent agents. Wholesale Brokerage distributes excess and surplus lines through independent agents and brokers. Services covers claims administration, medical utilization management for workers' compensation, Medicare Set-aside arrangements, Social Security disability support and claims adjusting.
Founded in 1939, Brown & Brown is headquartered in Daytona Beach, Florida, and its shares are listed on the NYSE under the ticker BRO.
Brown & Brown’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 55.6, in the Neutral zone, up 2.9 points over five sessions.
Up 2.9 points over five sessions.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 64 | +0.2% | +2.7% | ||
| Accumulation | 228 | −0.4% | −0.5% | ||
| Neutral (current zone) | 348 | +0.3% | −0.6% | ||
| Distribution | 61 | −0.2% | +2.3% | ||
| Selling | 1 | Too few readings yet | |||
Average BRO share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Brown & Brown trades 2.7% above Gekko Fair Value of $70.03, so the shares are about fair value on Gekko’s estimate.
Gekko’s own estimate of what Brown & Brown shares are worth, recalculated every trading day.
$70.03
Gekko Fair Value, Nov 14, 2026
2.7% above fair value · About fair value
At the end of Aug 2026 the price was 2.5% below the estimate.
No open-market insider purchases were filed for Brown & Brown, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for BRO in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in BRO were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Brown & Brown has been buying back its own shares.
From company filings.
0of the funds Gekko tracks hold BRO.
Brown & Brown reports on Jan 25, 2027 (71 days away), and beat the EPS estimate in 5 of its last 8 reports.
Jan 25, 2027
71 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Oct 26, 2026 | $1.07 est $1.09 | $1.73B est $1.76B | −7.4% |
| Jul 27, 2026 | $1.07 est $1.08 | $1.68B est $1.71B | +8.9% |
| Apr 27, 2026 | $1.39 est $1.36 | $1.90B est $1.89B | −4.2% |
| Jan 26, 2026 | $0.93 est $0.91 | $1.61B est $1.65B | −6.4% |
| Oct 27, 2025 | $1.05 est $0.94 | $1.61B est $1.55B | −6.4% |
| Jul 28, 2025 | $1.03 est $0.99 | $1.25B est $1.28B | −11.1% |
| Apr 28, 2025 | $1.29 est $1.29 | $1.39B est $1.41B | −5.6% |
| Jan 27, 2025 | $0.86 est $0.77 | $1.09B est $1.12B | −0.9% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Brown & Brown is $74.78, +4.0% from the last close, from 14 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 14 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 13 | Mizuho Securities | $84 | +16.8% |
| Nov 2 | J.P. Morgan | — | — |
| Nov 2 | KBW | $76 | +5.7% |
| Nov 2 | UBS | $72 | +0.1% |
| Oct 29 | Mizuho Securities | $81 | +12.6% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 14, Brown & Brown averaged +1.6% across the last 5 years, rising in 4 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.9% | 3 of 5 |
| Next 10 trading days | +0.9% | 4 of 5 |
| Next 15 trading days | +0.9% | 3 of 5 |
| Next 20 trading days | +1.6% | 4 of 5 |
| Next 30 trading days | −0.3% | 2 of 5 |
For scale, BRO’s typical 20-trading-day move in either direction is about 4.8%.
Brown & Brown’s market cap is $23.86B, with a P/E ratio of 22.3 and revenue of $6.81B over the last twelve months.
Coverage of Brown & Brown this week reads positive: 9 positive, 4 neutral and 0 negative headlines.
Brown & Brown’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| MRSHMarsh | Neutral | 7.1% above |
| AJGArthur J. Gallagher | Neutral | 4.4% above |
| AONAon | Neutral | 3.9% above |
| WTWWillis Towers Watson | Neutral | 0.7% below |
| RYANRyan Specialty | Neutral | 6.0% above |
| CRVLCorVel | Neutral | 10.4% above |
A peer links to its own page where one exists.
Brown & Brown’s market cap is $23.86B at the Nov 13, 2026 close of $71.93, with 331.7M shares outstanding. The shares trade on a P/E ratio of 22.3.
The consensus analyst 12-month price target for Brown & Brown is $74.78, +4.0% from the last close. Of the 14 firms that rated the stock in the last 90 days, 6 rate it a buy, 7 a hold and 1 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Brown & Brown is about fair value: the Nov 13, 2026 close of $71.93 is 2.7% above Gekko Fair Value of $70.03. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Brown & Brown is expected to report on Jan 25, 2027 (71 days away). Analysts expect earnings of $0.92 per share on revenue of $1.60B. Brown & Brown beat the earnings estimate in 5 of its last 8 reports, moving 6.4% on average across the report.
Brown & Brown’s 52-week high is $82.58 and its 52-week low is $53.81; it closed at $71.93 on Nov 13, 2026, −10.3% over the past year. Over the last five years the shares peaked at $125.68 on Apr 1, 2025.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (trend, earnings risk and seasonality), 2 as mixed (gekkoindex and fair value). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.